InMode (INMD) Current Deferred Tax Assets (2018 - 2026)

InMode (INMD) posted Current Deferred Tax Assets of $52.9 million for Q1 2026, down 0.58% sequentially from $53.2 million in Q4 2025.

InMode (INMD) Current Deferred Tax Assets (2018 - 2026) Analysis & Trends

InMode has reported Current Deferred Tax Assets for 4 years, with the latest figure at $52.9 million in Q1 2026.

Quarterly Current Deferred Tax Assets changed N/A year-over-year to $52.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.9 million (changed N/A YoY) and the FY2025 annual result came in at $53.2 million, changed N/A from the prior year.
Current Deferred Tax Assets eased to $52.9 million in Q1 2026 per INMD's latest filing, from $53.2 million in the prior quarter.
Over five years, Current Deferred Tax Assets peaked at $53.2 million in Q4 2025 and troughed at $52.9 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	InMode	912.51 Mn	497.35 Mn	71.52 Mn

Download Data